ArticleTheranostics2022

Identification of a miRNA-based non-invasive predictive biomarker of response to target therapy in BRAF-mutant melanoma.

Ciro Francesco Ruggiero et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.